Sumitomo Pharma America, Inc.

This early-stage study is testing whether implanting lab-grown dopamine-producing cells into the brain is safe and can help control Parkinson's disease symptoms. It will involve about 25 patients with moderate Parkinson's who haven't responded well to standard medications. Some p…

This is an early-stage study to test the safety and find the right dose of a new drug called SMP-3124LP for adults with advanced solid tumors that have progressed after standard treatments. The trial will also look for early signs that the drug can help control the cancer. It is …

This study is testing a new oral drug called enzomenib for people with advanced blood cancers like acute leukemia that have come back or not responded to other treatments. The main goals are to find a safe and effective dose and to see if the drug, given alone or with standard ch…

This study is testing a new oral medication called nuvisertib for people with intermediate or high-risk myelofibrosis, a serious bone marrow cancer. It aims to find a safe dose and see if the drug can reduce spleen size and ease symptoms. The trial is enrolling about 240 patients…

This early-stage study is testing the safety of a new treatment for retinitis pigmentosa, a genetic eye disease that causes vision loss. Researchers will implant lab-grown retinal tissue into the eyes of 12 adult participants to see if it's safe and if it might help preserve or i…